Scientists have been seeking for years to develop treatments for obesity that help reduce appetite without negatively affecting the body’s energy or muscle mass. Despite the progress achieved by modern medicines, there are still challenges related to side effects or loss of metabolic balance.
In this context, scientific research is increasingly turning to nature, in search of biological models that can offer different and more accurate solutions.
A being with extraordinary powers
Among these models, snakes have drawn the attention of scientists because of their exceptional ability to handle food. Some types of snakes can eat huge meals approximately equal to their size, and then remain for long periods without food, while maintaining normal body functions.
This unusual behavior has led researchers to try to understand the mechanisms that allow it to regulate appetite and energy so efficiently.
A recent scientific study published in the journal Nature Metabolism revealed a molecule found in the blood of snakes that may form the basis for developing a new generation of weight-loss drugs.
The study, led by researchers from Stanford, Colorado, and Baylor universities, focused on understanding how snakes deal with huge meals without losing their metabolic balance.
The study relied on analyzing the blood of types of snakes, especially the Burmese snake, before and after eating, with the aim of tracking the chemical changes that accompany the digestion process.
When studying what happens inside the snake’s body after eating, it turns out that there are rapid and significant changes in metabolic processes. The rate of burning energy increases significantly, and vital organs work more efficiently to digest the meal. These changes do not occur randomly, but are regulated by a complex network of chemical signals that travel through the blood.
Discovery of the pTOS molecule
To understand this process more precisely, the researchers analyzed the components of snake blood before and after feeding. This analysis revealed hundreds of compounds whose concentration changes after eating, but one of these compounds was the most interesting. This molecule is known as “pTOS”, and it has been observed that its level increases very significantly after eating compared to the fasting state.
When scientists tested this molecule on obese animals, the results were remarkable. It reduced the amount of food eaten by these animals and contributed to weight loss, without causing a decrease in activity or loss of muscle mass.
The importance of these results lies in that they address one of the most prominent problems with current obesity medications, which may sometimes affect the body’s energy or muscle structure.
Direct targeting
Preliminary studies indicate that this molecule works in a different way than most currently available drugs. Instead of affecting the stomach or slowing down the digestion process, it appears to directly target areas of the brain responsible for regulating feelings of hunger and fullness. This means that it may help reduce the desire to eat from the source, i.e. from the nerve signals themselves.
One of the points that reinforces the importance of this discovery is that this compound is not completely foreign to the human body, but is found in it in small quantities, and it increases naturally after eating. This may facilitate its development as a treatment in the future. Because it depends on a mechanism that already exists in the body, and not on the introduction of a completely foreign substance.
In contrast, most current obesity medications are based on effects on the digestive system or related hormones. Despite their effectiveness, they may cause side effects such as nausea or digestive disorders. This new discovery raises the possibility of developing a treatment that works in a more balanced way, by regulating appetite without significantly affecting the rest of the body’s functions.
However, this line of research is still in its early stages. So far, experiments have been conducted only on animals, and extensive clinical studies in humans have not yet begun. This means that there is still a long way to go before confirming the effectiveness and safety of this molecule for medical use.
Expected challenges
Researchers point out that the challenges ahead include determining appropriate doses, understanding long-term effects, and ensuring that there are no unexpected side effects. The success of the results in animals does not necessarily guarantee that they will be repeated in the same way in humans, which requires more caution and study.
Despite these reservations, this discovery reflects an important trend in scientific research, which is based on taking advantage of natural models to understand the human body more deeply. Instead of developing medications that rely solely on suppressing appetite in traditional ways, scientists are turning to trying to “reset” the hunger mechanisms themselves, in order to achieve a better balance between the need for food and maintaining health.
If these results prove effective in the future, we may witness a new generation of obesity medications that rely on precise regulation of appetite, without affecting energy or muscle mass, which may represent an important shift in the way of dealing with one of the most widespread health problems in the world.